Predoctoral Training Program in Molecular Pharmacology and Experimental Therapeutics Student Roster

Director

Larry M. Karnitz, Ph.D.

Review the focus areas, mentors and publications of current and former trainees in the Predoctoral Training Program in Molecular Pharmacology and Experimental Therapeutics at Mayo Clinic.

Appointee	Mentor(s)	Research focus	Mayo Clinic publications
Elizabeth K. Wiese	Taro Hitosugi, Ph.D.	The role of SDR9C7 in multiple myeloma	Publications on PubMed
Jordan M. Grainger	Liewei Wang, M.D., Ph.D.	Study of copy number amplification and chemo-response in triple negative breast cancer	Publications on PubMed
Erin M. Higgins	Michael J. Ackerman, M.D., Ph.D.	Elucidation of MRAS-mediated Noonan syndrome with cardiac hypertrophy	Publications on PubMed
Rebecca L. Kelly	Larry M. Karnitz, Ph.D.	Kinetic parameters for the metabolism of endoxifen	Publications on PubMed
Drew R. Neavin, Ph.D.	Richard Weinshilboum, M.D.	Metabolomics and single nucleotide polymorphism analyses to identify genetic components of response to SSRIs	Publications on PubMed
Sherri M. Biendarra-Tiegs	Timothy J. Nelson, M.D., Ph.D.	Patient-derived induced pluripotent stem cells to investigate cardiac drug toxicities	Publications on PubMed
Christopher Livia	Atta Behfar, M.D., Ph.D.	Mechanisms of reperfusion injury after myocardial ischemia and regenerative therapies to treat ischemia	Publications on PubMed
Katherine Minter Dykhouse	Timothy J. Nelson, M.D., Ph.D.	Modeling terminal differentiation of cardiomyocytes using the directed differentiation of human induced pluripotent stem cells to cardiomyocytes	Publications on PubMed
Stephanie L. Safgren, Ph.D., M.S.	Martin E. Fernandez-Zapico, M.D.	The chromatin remodeler SMARCA2 cooperates with GLI1 to regulate gene expression in pancreatic cancer cells	Publications on PubMed
Cordelia D. McGehee	Scott H. Kaufmann, M.D., Ph.D. Hu Li, Ph.D.	Identification of mechanisms of treatment resistance and responsiveness in ovarian cancer using systems pharmacology	Publications on PubMed
Carl T. Gustafson	Michael J. Yaszemski, M.D., Ph.D.	Wnt targets and therapeutic approaches in osteosarcoma	Publications on PubMed
Jamie D. Kapplinger, M.D., Ph.D.	Michael J. Ackerman, M.D., Ph.D.	Enhanced classification of non-synonymous single nucleotide variants in the SCN5A-encoded Nav1.5 cardiac sodium channel	Publications on PubMed
Alfreda D. Nelson	Diana Gil Pages, Ph.D.	Anti-TCR-CD3 fab homodimerization and the effects of ligand bivalency on T cell activation	Publications on PubMed

Review career outcomes for alumni of the T32 Predoctoral Training Program in Molecular Pharmacology and Experimental Therapeutics (MPET) at Mayo Clinic:

Current career	Former MPET T32 Ph.D. and M.D.-Ph.D. trainees*
Research — academic faculty	42%
Research — academic staff	17%
Research — industry	17%
Research — government	8%
Teaching — faculty	8%
Medical practice	0%
Other industry or medical career	8%
*Trainees supported by the National Institute of General Medical Sciences-funded Predoctoral Training Program in Molecular Pharmacology and Experimental Therapeutics (MPET) for the last 15 years.